Results show a personalized liquid biopsy detecting tiny cancer DNA amounts can predict cancer recurrence earlier than symptoms appear, allowing timely treatment interventions.
Early detection enables better treatment outcomes and may prevent cancer metastasis, enhancing the chance of curing the disease.
Researchers identified relapsed patients accurately up to 41 months before using the test, potentially revolutionizing breast cancer management for improved survival rates.
[
add
]
[
|
|
...
]